Cancer Incidence and Mortality among Asians and Pacific Islander Individuals, New York State Excl New York City, 2016-2020
Source: New York State Cancer Registry
Site of Cancer | Incidence | Mortality | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Males and Females | Males | Females | Males and Females | Males | Females | |||||||||||||
Average Annual Cases | Rate per 100,000 Population | 95% CI | Average Annual Cases | Rate per 100,000 Males | 95% CI | Average Annual Cases | Rate per 100,000 Females | 95% CI | Average Annual Deaths | Rate per 100,000 Population | 95% CI | Average Annual Deaths | Rate per 100,000 Males | 95% CI | Average Annual Deaths | Rate per 100,000 Females | 95% CI | |
All Invasive Malignant Tumors | 1,535.8 | 311.7 | 304.6-318.9 | 692.0 | 306.7 | 296.3-317.4 | 843.8 | 316.7 | 307.0-326.5 | 354.0 | 78.7 | 74.9-82.5 | 179.0 | 87.7 | 81.9-93.8 | 175.0 | 71.2 | 66.5-76.2 |
Oral cavity and pharynx | 47.0 | 9.4 | 8.2-10.7 | 30.6 | 12.9 | 10.9-15.2 | 16.4 | 6.3 | 5.0-7.8 | 6.8 | 1.5 | 1.0-2.1 | 3.8 | 1.9 | 1.1-3.0 | 3.0 | 1.2 | 0.7-2.0 |
Esophagus | 12.0 | 2.6 | 2.0-3.4 | 8.6 | 4.1 | 2.9-5.6 | 3.4 | 1.3 | 0.8-2.2 | 6.8 | 1.5 | 1.0-2.1 | 4.8 | 2.3 | 1.5-3.5 | 2.0 | 0.8 | 0.4-1.6 |
Stomach | 43.2 | 9.2 | 7.9-10.5 | 23.8 | 10.9 | 9.0-13.1 | 19.4 | 7.7 | 6.2-9.4 | 17.0 | 3.8 | 3.0-4.7 | 8.8 | 4.2 | 3.0-5.7 | 8.2 | 3.4 | 2.4-4.6 |
Colorectal | 135.8 | 28.1 | 26.0-30.3 | 67.8 | 29.7 | 26.5-33.1 | 68.0 | 26.5 | 23.7-29.6 | 38.2 | 8.7 | 7.5-10.1 | 20.8 | 10.4 | 8.4-12.7 | 17.4 | 7.3 | 5.8-9.0 |
Colon excluding rectum | 82.8 | 17.3 | 15.7-19.1 | 39.2 | 17.2 | 14.8-19.9 | 43.6 | 17.2 | 15.0-19.7 | 29.4 | 6.8 | 5.7-8.0 | 16.2 | 8.2 | 6.4-10.2 | 13.2 | 5.5 | 4.3-7.1 |
Rectum & rectosigmoid | 53.0 | 10.8 | 9.5-12.2 | 28.6 | 12.5 | 10.5-14.7 | 24.4 | 9.3 | 7.7-11.1 | 8.8 | 2.0 | 1.4-2.7 | 4.6 | 2.2 | 1.4-3.4 | 4.2 | 1.7 | 1.1-2.7 |
Liver / intrahepatic bile duct | 50.0 | 10.3 | 9.0-11.6 | 33.8 | 14.5 | 12.4-17.0 | 16.2 | 6.5 | 5.1-8.1 | 32.2 | 7.1 | 6.0-8.3 | 20.6 | 9.7 | 7.8-11.8 | 11.6 | 4.9 | 3.7-6.4 |
Pancreas | 46.6 | 10.1 | 8.8-11.5 | 23.6 | 10.8 | 8.9-13.0 | 23.0 | 9.4 | 7.7-11.3 | 28.2 | 6.3 | 5.2-7.4 | 15.4 | 7.2 | 5.6-9.1 | 12.8 | 5.4 | 4.1-6.9 |
Larynx | 6.0 | 1.2 | 0.8-1.7 | 4.8 | 2.1 | 1.3-3.2 | 1.2 | 0.4 | 0.1-0.9 | 1.4 | 0.3 | 0.1-0.6 | 1.4 | 0.6 | 0.2-1.3 | 0.0 | 0.0 | 0.0-0.3 |
Lung and bronchus | 145.2 | 30.5 | 28.3-32.9 | 77.0 | 35.2 | 31.7-39.1 | 68.2 | 26.4 | 23.7-29.5 | 64.6 | 14.4 | 12.8-16.1 | 35.6 | 17.3 | 14.7-20.1 | 29.0 | 11.9 | 10.0-14.1 |
Melanoma of the skin | 8.6 | 1.8 | 1.3-2.4 | 4.6 | 2.0 | 1.3-3.0 | 4.0 | 1.5 | 0.9-2.4 | 1.0 | 0.2 | 0.1-0.5 | 0.8 | 0.4 | 0.1-1.1 | 0.2 | 0.1 | 0.0-0.4 |
Female breast | 294.4 | 107.7 | 102.2-113.4 | 25.2 | 9.8 | 8.2-11.7 | ||||||||||||
Cervix uteri | 14.2 | 5.2 | 4.1-6.6 | 4.0 | 1.5 | 0.9-2.4 | ||||||||||||
Corpus uterus and NOS | 58.4 | 20.6 | 18.3-23.1 | 7.2 | 2.7 | 1.9-3.8 | ||||||||||||
Ovary | 27.4 | 10.2 | 8.6-12.1 | 11.0 | 4.3 | 3.2-5.6 | ||||||||||||
Prostate | 166.8 | 73.0 | 68.0-78.3 | 11.6 | 6.4 | 4.8-8.4 | ||||||||||||
Testis | 6.4 | 2.4 | 1.6-3.4 | 0.0 | 0.0 | 0.0-0.3 | ||||||||||||
Urinary bladder (incl. in situ) | 43.8 | 9.7 | 8.4-11.1 | 34.0 | 16.2 | 13.8-18.9 | 9.8 | 4.2 | 3.1-5.5 | 4.2 | 1.0 | 0.6-1.6 | 3.6 | 2.0 | 1.1-3.1 | 0.6 | 0.3 | 0.1-0.8 |
Kidney and renal pelvis | 42.6 | 8.3 | 7.2-9.6 | 29.2 | 12.2 | 10.2-14.4 | 13.4 | 5.0 | 3.9-6.4 | 4.2 | 1.0 | 0.6-1.5 | 2.2 | 1.1 | 0.5-2.0 | 2.0 | 0.8 | 0.4-1.6 |
Brain and other central nervous system | 19.8 | 4.0 | 3.2-4.9 | 11.2 | 4.5 | 3.4-5.9 | 8.6 | 3.4 | 2.5-4.6 | 11.4 | 2.4 | 1.8-3.1 | 6.4 | 2.8 | 1.9-3.9 | 5.0 | 2.0 | 1.3-2.9 |
Thyroid | 96.4 | 18.2 | 16.6-19.9 | 21.4 | 8.7 | 7.1-10.5 | 75.0 | 26.7 | 24.1-29.6 | 2.0 | 0.4 | 0.2-0.8 | 0.6 | 0.3 | 0.1-0.9 | 1.4 | 0.5 | 0.2-1.1 |
Hodgkin lymphoma | 8.4 | 1.4 | 1.0-2.0 | 4.2 | 1.6 | 1.0-2.4 | 4.2 | 1.4 | 0.8-2.1 | 0.8 | 0.2 | 0.0-0.4 | 0.4 | 0.1 | 0.0-0.5 | 0.4 | 0.2 | 0.0-0.6 |
Non-Hodgkin lymphomas | 69.8 | 14.3 | 12.8-15.9 | 38.2 | 17.1 | 14.7-19.7 | 31.6 | 11.9 | 10.1-14.0 | 15.4 | 3.4 | 2.7-4.3 | 9.4 | 4.5 | 3.3-6.0 | 6.0 | 2.5 | 1.7-3.6 |
Myeloma | 22.2 | 4.5 | 3.7-5.4 | 14.6 | 6.4 | 4.9-8.1 | 7.6 | 2.9 | 2.0-4.0 | 4.6 | 1.0 | 0.6-1.6 | 2.0 | 1.1 | 0.5-2.0 | 2.6 | 1.0 | 0.5-1.8 |
Leukemias | 40.4 | 8.4 | 7.2-9.6 | 23.0 | 10.4 | 8.6-12.6 | 17.4 | 6.6 | 5.3-8.1 | 14.6 | 3.2 | 2.5-4.1 | 9.6 | 4.8 | 3.5-6.5 | 5.0 | 1.9 | 1.2-2.9 |
Notes
- Incidence data are provisional, November 2022.
- Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
- Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.
- NYSCR mortality statistics might differ slightly from official mortality statistics due to the availability of additional demographic information.